Condition
Myelodysplastic Neoplasms clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Myelodysplastic Neoplasms clinical trials that are recruiting, at sites in 2 countries (most in Germany (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
First-line luspatercept use in adults with lower-risk transfusion-dependent MDS
This study follows adults with lower-risk MDS who start luspatercept as part of usual care to see how often they need fewer transfusions and how their blood counts and quality of life change over up to two years.
-
Venetoclax plus azacitidine as a bridge to stem-cell transplant for higher-risk MDS-IB2
This will test whether 1–2 cycles of venetoclax with azacitidine can lower bone marrow blasts and help adults with higher‑risk MDS‑IB2 reach allogeneic stem-cell transplantation.
Related topics
Quick answers
How many Myelodysplastic Neoplasms clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Germany (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.